UCLA Montecito Primary & Specialty Care

Clinical research site in Montecito, California

Part of UCLA

As of July 2026, 1 paid clinical trial is recruiting at UCLA Montecito Primary & Specialty Care in Montecito, California. Active studies at this site focus on Urothelial Carcinoma alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at UCLA Montecito Primary & Specialty Care (1)

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

for Urothelial Carcinoma

144 locations incl. Gilbert

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT04879329·Phase 2·Recruiting·Listed May 2021

Apply to this trial

Explore more

Paid clinical trials in Montecito, CA · California clinical trials